Bioline Rx reported $-673K in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Arca Biopharma USD -25.09M 5.23M Mar/2025
Bio Path USD -3.24M 616K Mar/2025
Bioline Rx USD -673K 2.99M Sep/2025
Capricor Therapeutics USD -24.98M 17.28M Mar/2025